The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation
Author
Wang, H.Berger, K.N.
Miller, E.L.
Fu, W.
Broglie, L.
Goldman, F.D.
Konig, H.
Lim, S.J.
Berg, A.S.
Talano, J.-A.
Comito, M.A.
Farag, S.S.
Pu, J.J.
Affiliation
Cancer Center, The University of ArizonaIssue Date
2023-05-03Keywords
Myeloablative considitionpost cord blood hematological stem cell transplant outcome
reduced-intensity condition
total body irradiation
umbilical cord blood hematopoietic stem cell transplantation
Metadata
Show full item recordPublisher
SAGE Publications LtdCitation
Wang H, Berger KN, Miller EL, et al. The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation. Therapeutic Advances in Hematology. 2023;14. doi:10.1177/20406207231170708Rights
© The Author(s), 2023. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background: Umbilical cord blood hematopoietic stem cells are commonly used for hematopoietic system reconstitution in recipients after umbilical cord blood transplantation (UCBT). However, the optimal conditioning regimen for UCBT remains a topic of debate. The exact impact of total body irradiation (TBI) as a part of conditioning regimens remains unknown. Objectives: The aim of this study was to evaluate the impacts of TBI on UCBT outcomes. Design: This was a multi-institution retrospective study. Methods: A retrospective analysis was conducted on the outcomes of 136 patients receiving UCBT. Sixty-nine patients received myeloablative conditioning (MAC), in which 33 underwent TBI and 36 did not, and 67 patients received reduced-intensity conditioning (RIC), in which 43 underwent TBI and 24 did not. Univariate and multivariate analyses were conducted to compare the outcomes and the post-transplant complications between patients who did and did not undergo TBI in the MAC subgroup and RIC subgroup, respectively. Results: In the RIC subgroup, patients who underwent TBI had superior overall survival (adjusted hazard ratio [aHR] = 0.25, 95% confidence interval [CI]: 0.09–0.66, p = 0.005) and progression-free survival (aHR = 0.26, 95% CI: 0.10–0.66, p = 0.005). However, in the MAC subgroup, there were no statistically significant differences between those receiving and not receiving TBI. Conclusion: In the setting of RIC in UCBT, TBI utilization can improve overall survival and progression-free survival. However, TBI does not show superiority in the MAC setting. © The Author(s), 2023.Note
Open access journalISSN
2040-6207Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1177/20406207231170708
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s), 2023. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License.

